ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

ClinicalTrials.gov ID: NCT05111626

Public ClinicalTrials.gov record NCT05111626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression

Study identification

NCT ID
NCT05111626
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
515 participants

Conditions and interventions

Interventions

  • Bemarituzumab Drug
  • Chemotherapy Drug
  • Nivolumab Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2022
Primary completion
Oct 13, 2025
Completion
Jan 28, 2027
Last update posted
Dec 14, 2025

2022 – 2027

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Mayo Clinic - Arizona Phoenix Arizona 85054
The Oncology Institute Clinical Research Cerritos California 90703
Cancer and Blood Specialty Clinic Downey California 90241
City of Hope National Medical Center Duarte California 91010
University of California Los Angeles Los Angeles California 90095
University of California Irvine Orange California 92868
Torrance Memorial Physician Network Redondo Beach California 90277
Translational Research in Oncology - US Inc Santa Monica California 90404
Translational Research in Oncology US Inc, Trio Central Pharmacy Santa Monica California 90404
Olive View-University of California in Los Angeles Medical Center Sylmar California 91342
Presbyterian Intercommunity Hospital Health Whitter Hospital Whittier California 90602
Yale New Haven Hospital Yale Cancer Center New Haven Connecticut 06520
Florida Cancer Specialists - Fort Myers Fort Myers Florida 33901
Mayo Clinic Jacksonville Florida 32224
Adventist Health System/Sunbelt, Inc d/b/a AdventHealth Orlando Orlando Florida 32804
Orlando Health Cancer Institute Orlando Florida 32806
University of Illinois Chicago Chicago Illinois 60612
Greater Baltimore Medical Center Baltimore Maryland 21204
Henry Ford Health System Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
Summit Medical Group Florham Park New Jersey 07932
Memorial Sloan Kettering Cancer Center New York New York 10022
Stony Brook University Medical Center Stony Brook New York 11794-7263
FirstHealth Cancer Center Pinehurst North Carolina 28374
Gabrail Cancer Center, LLC Canton Ohio 44718
Providence Cancer Institute Franz Clinic Portland Oregon 97213
Saint Lukes University Health Network Allentown Pennsylvania 18104
Medical University of South Carolina Charleston South Carolina 29425
West Cancer Center Germantown Tennessee 38138
Sarah Cannon Research Institute Nashville Tennessee 37203
Texas Oncology Central-South Austin Texas 78705
University of Texas MD Anderson Cancer Center Houston Texas 77030
United States Oncology Regulatory Affairs Corporate Office The Woodlands Texas 77380
US Oncology Research Investigational Products Center The Woodlands Texas 77380
Virginia Oncology Associates Norfolk Virginia 23502
Northwest Cancer Specialists - Vancouver Vancouver Washington 98684
Aurora Health Care Metro Inc Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 311 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05111626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 14, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05111626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →